The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation-Reference-Cited by-同舟云学术

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation

Published:2006-06 Issue:6 Volume:133 Page:591-605
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Hay Charles R. M.,Brown S.,Collins P. W.,Keeling D. M.,Liesner R.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06087.x/fullpdf

Reference118 articles.

1. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors

2. Agency of Health Care Policy and Research. (1992 ) Acute Pain Management: Operative or Medical Procedures and Trauma (Agency of Health Care Policy and Research Publications). Clinical Pharmacology , 11 , 391 -414 .

3. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity

4. Comparative thrombotic event incidence after infusion of recombinant factor VIIa vs. factor VIII inhibitor bypass activity-reply to a rebuttal

5. The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extensive ecchymosis and retroperitoneal hemorrhage due to acquired hemophilia-A following influenza vaccination: A case report;Medicine;2024-05-24

2. Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis;Hämostaseologie;2024-03-01

3. Race, ethnicity, and immune tolerance induction in hemophilia A in the United States;Research and Practice in Thrombosis and Haemostasis;2023-11

4. Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan;Haemophilia;2023-10-11

5. The prophylaxis of severe hemophilia A with inhibitors in children in the Republic of Belarus: a 12-year experience;Pediatric Hematology/Oncology and Immunopathology;2023-10-01